Serum Peroxiredoxin3 is a Useful Biomarker for Early Diagnosis and Assessemnt of Prognosis of Hepatocellular Carcinoma in Chinese Patients
Liang Shi(National Instruments (Ireland)), Xiangyang Lin, Haixia Huang(Capital Medical University), Liu Cun-li, Zengqiang Chen(Nankai University), Sheng-Ying Chi, Xiaofei Chen(Tsinghua University), Yi Zhang(Tianjin Medical University General Hospital), Jianrong Yang, Jiaying Zheng(Chinese University of Hong Kong), Fujun Yu(Wenzhou Medical University), Li Wu(University of Iowa)
Cited by 22
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k
Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
|Archives of General Psychiatry|2010|402